Clinical Trial Update: Ferumoxytol Enhanced Magnetic Resonance Angiography in Chronic Kidney Disease

View source ↗

Summary

Clinical trial evaluating ferumoxytol-enhanced magnetic resonance angiography in chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Ferumoxytol (Feraheme) (ferumoxytol)

Snippet

Sponsor: Sokratis Stoumpos | Conditions: Ferric Compounds, Magnetic Resonance Angiography | Status: COMPLETED